Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-138722
Filing Date
2016-08-25
Accepted
2016-08-25 21:54:30
Documents
1
Period of Report
2016-08-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4086
  Complete submission text file 0001209191-16-138722.txt   5493
Mailing Address C/O ALEXION PHARMACEUTICALS INC 352 KNOTTER DRIVE CHESHIRE CT 06410
Business Address
SQUINTO STEPHEN P (Reporting) CIK: 0001231954 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37833 | Film No.: 161852679

Mailing Address 101 MONTGOMERY STREET, SUITE 2650 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2650 SAN FRANCISCO CA 94104 415-638-6556
Audentes Therapeutics, Inc. (Issuer) CIK: 0001628738 (see all company filings)

EIN.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)